Company
4 appearances
Latest appearance 2026-02-26
Isabel Kalofonos
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Isabel Kalofonos
The company reported in an 8-K filed December 16, 2024 that Isabel Kalofonos was appointed Chief Commercial Officer, effective December 16, 2024. Isabel Kalofonos has spoken on 4 earnings calls across 1 company, most recently on February 26, 2026.
“On December 16, 2024, Crinetics Pharmaceuticals, Inc. (the "Company" or "Crinetics") announced the appointment of Isabel Kalofonos as Chief Commercial Officer, which was effective as of December 16, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Earnings call
Crinetics Pharmaceuticals, Inc. Q4 FY2025 Earnings Call
-
Earnings call
Crinetics Pharmaceuticals, Inc. Q3 FY2025 Earnings Call
-
Earnings call
Crinetics Pharmaceuticals, Inc. Q2 FY2025 Earnings Call
-
Earnings call
Crinetics Pharmaceuticals, Inc. Q1 FY2025 Earnings Call
-
Executive change Appointed: Chief Commercial Officer